Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Autoantibodies to Glutamate Receptor Antigens in Multiple Sclerosis and Rasmussen's Encephalitis.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
The Central Role of Neuroscientists under National Socialism.
Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
Central auditory processing and word discrimination in patients with multiple sclerosis.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Objectively Quantified Physical Activity in Persons with Multiple Sclerosis.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.]
Marijuana Legalization: Impact on Physicians and Public Health.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
Regulatory B Cells and Mechanisms.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Genital and sexual pain in women.
Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.
Composite end points to assess delay of disability progression by MS treatments.
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
High-throughput sequencing of immune repertoires in multiple sclerosis.

Pages